Director, Global Medical Oncology, US IO Lung Cancer Portfolio at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Advanced scientific degree (PharmD, MD, PhD, PA/NP)
Prior (5+ years) pharmaceutical industry experience in medical affairs is preferred
Highly organized and motivated individual with the ability to lead multiple projects and initiatives across diverse high performing matrix teams
Possess excellent communication and presentation skills, both verbal and written
Understand pharmaceutical drug development including clinical development, regulatory, life cycle management of pharmaceutical products, and collaboration

Responsibilities

Collaborate with Medical Product Lead for US medical plan that is both product and disease specific in alignment with US Commercialization (USC) and Global Medical, translating strategies into effective US Medical launch plans and life cycle management plans
Provide strategic, scientific, and executional leadership while partnering with the integrated matrix team, including Medical, Commercial, and Access organizations
Develop/refine and implement key medical activities, including medical advisory boards, Scientific Engagement Partner resources and training, congresses, reactive content, and communication strategy, including publications
Establish data generation strategies and collaborate with Medical Evidence Generation (MEG) to oversee the execution of the Investigator-Sponsored Research (ISR) programs from concept through full execution, including reporting the evidence at scientific congresses, in peer-reviewed publications, and proactive/reactive BMS communication tools
Collaborate within Medical matrix teams (Field Medical, Data Generation, Patient Advocacy, Medical Education, and Congress Management) to plan and deliver medical objectives with flawless execution and budget utilization
Partner closely with colleagues in Discovery, Clinical Research, Regulatory, and Health Outcomes to ensure the science of the pipeline products and marketed medicines is understood and communicated properly internally and externally
Collaborate and communicate with US Commercialization & Access organizations to integrate medical perspectives into the commercialization process and ensure appropriate alignment between commercial and medical plans
Develop and maintain long-term, trusted relationships with external Thought Leaders and scientific experts to assess unmet medical needs and develop appropriate medical strategies
Ensure medical strategies, objectives, and tactics are aligned across the medical matrix and integrated with the strategic brand plan

Skills

Oncology

Immuno-Oncology

Medical Strategy

Cross-Functional Collaboration

Medical Advisory Boards

Scientific Engagement

Lifecycle Management

Commercialization

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free